Latest Statins Stories
This study’s publication comes as thousands of Lipitor lawsuits that allege the statin medication caused Type 2 diabetes continue to move through U.S.
All six trials met primary efficacy endpoint TARRYTOWN, N.Y. and PARIS, Nov. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- All six trials met primary efficacy endpoint - PARIS AND TARRYTOWN, N.Y., Nov. 19, 2014 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
The Firm is evaluating Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of the cholesterol-lowering medication. New
Trial will evaluate if a daily dose of the statin, pitavastatin, can reduce the elevated risk of cardiovascular disease in this patient population MONTGOMERY, Ala., Oct.
A Rise In Lipitor Lawsuit Claims Jumped In Five Months With Filings That Contend Development Of Type 2 Diabetes After Taking The Cholesterol Lowing Medication, Notes Wright & Schulte LLC
Lawsuit Funding Network has secured investors to assist victims who have developed Type-II Diabetes while either taking Lipitor or Crestor. Lake Zurich IL (PRWEB)
As Lipitor Lawsuits Await Litigation The First Bellwether Trial Has Been Scheduled For July of 2015 With Depositions to Start This August Reports Wright & Schulte LLC Columbus,
On June 24, the FDA announced that 7,379 bottles (lot 3121005) of Red Yeast Rice dietary supplement, by Doctor's Best, are recalled because they were found to contain undeclared Lovastatin.
The just-filed lawsuit was filed by a group of consumers who allege that the maker and distributor of Crestor, prescribed to lower cholesterol levels, allegedly hid information on the drug’s
- totally perplexed and mixed up.